A bone-derived growth factor isolated from rat calvariae is beta 2 microglobulin

Area of Science:

• Biochemistry
• Molecular Biology
• Orthopedics

Background:

• Rat calvariae secrete a bone-derived growth factor (BDGF) that promotes bone matrix synthesis.
• The precise identity and function of BDGF in bone metabolism were previously unknown.

Purpose of the Study:

• To purify and characterize the bone-derived growth factor (BDGF) secreted by rat calvariae.
• To determine the molecular identity of BDGF and its role in regulating bone formation.

Main Methods:

• Purification of BDGF from rat calvarial culture medium using dialysis, gel filtration, and High-Performance Liquid Chromatography (HPLC).
• Amino acid composition and N-terminal sequence analysis of purified BDGF.
• Western blot analysis using a polyclonal antibody against beta 2 microglobulin (β2m).
• Assessment of the effects of purified BDGF and human β2m on bone cell DNA and protein synthesis in vitro.

Main Results:

• BDGF purification yielded a protein whose amino acid composition and N-terminal sequence were identical to mature murine beta 2 microglobulin (β2m).
• Western blot analysis confirmed the identity of BDGF as β2m.
• Both BDGF and human β2m significantly stimulated bone DNA, collagen, and noncollagen protein synthesis, indicating a conserved function.

Conclusions:

• Bone-derived growth factor (BDGF) is homologous to beta 2 microglobulin (β2m).
• Beta 2 microglobulin (β2m) acts as an autologous regulator of bone formation by stimulating bone cell synthesis.
• These findings identify β2m as a novel factor involved in skeletal tissue regulation.